Milestone Pharmaceuticals Balance Sheet (2018-2026)

Reported Financials

Milestone Pharmaceuticals Quarterly Balance Sheet

Periods 34 quarters

Latest Jun 2026

Milestone Pharmaceuticals reported total assets of $181.62M and total liabilities of $163.41M for the quarter ended Jun 2026, up 283.0% year over year. This balance sheet covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	111.43M	114.14M	92.24M	63.24M	37.29M	7.64M	73.95M	32.59M	9.88M	13.76M	10.13M	13.26M	12.80M	25.31M	45.09M	42.50M	46.69M	73.05M	71.32M	169.73M
Short-term InvestmentsInvestments (Current)	15.00M		8.00M	23.00M	39.95M	56.95M	27.00M	55.00M	65.87M	52.24M	79.35M	69.99M	63.62M	44.40M	10.87M	0.92M	35.90M	32.91M	112.90M	0.90M
Cash & Current Investments	126.40M	114.10M	100.20M	86.20M	77.20M	64.50M	101.00M	87.60M	75.70M	66.00M	89.50M	83.30M	76.40M	69.70M	56.00M	43.40M	82.60M	106.00M	184.20M	170.60M
Receivables - NetNet Receivables																			1.61M	2.72M
Receivables - OtherOther Receivables	0.09M	0.13M	0.25M	0.26M	0.44M	0.88M	0.69M	1.09M	1.52M	3.21M	1.41M	1.62M	1.21M	1.49M	1.17M	0.92M	0.70M	1.65M	1.43M	0.73M
Receivables																			3.03M	3.45M
Work In Process																		0.52M	1.61M	4.35M
Finished Goods																		0.13M	0.21M	0.38M
Inventory																		0.65M	1.83M	4.72M
Prepaid Assets	5.97M	4.30M	4.07M	3.47M	5.06M	6.01M	5.45M	5.40M	6.96M	3.18M	2.36M	1.71M	2.52M	1.84M	2.36M	0.75M	2.58M	1.81M	1.21M	1.04M
Current Assets	132.76M	118.92M	104.97M	90.50M	82.92M	71.80M	108.51M	94.57M	84.80M	73.03M	93.97M	87.36M	80.99M	73.93M	60.48M	46.17M	86.67M	111.92M	192.25M	180.33M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	0.24M	0.22M	0.19M	0.23M	0.30M	0.26M	0.27M	0.28M	0.27M	0.28M	0.25M	0.22M	0.20M	0.20M	0.18M	0.16M	0.14M	0.51M	0.50M	0.47M
Non-Current Assets	1.02M	0.93M	0.83M	0.80M	2.85M	2.68M	2.57M	2.45M	2.32M	2.19M	2.03M	1.87M	1.72M	1.57M	1.41M	1.25M	1.08M	1.64M	1.48M	1.30M
Assets	133.78M	119.85M	105.80M	91.30M	85.77M	74.48M	111.08M	97.02M	87.12M	75.23M	96.00M	89.23M	82.71M	75.50M	61.89M	47.42M	87.75M	113.56M	193.73M	181.63M
Liabilities
Current Liabilities
Accounts Payables	5.59M	6.55M	4.41M	4.09M	6.04M	5.64M	7.42M	6.29M	7.58M	6.68M	3.58M	4.00M	4.68M	7.56M	12.42M	8.77M	10.04M	5.65M	10.02M	8.45M
Payables	5.59M	6.55M	4.41M	4.09M	6.04M	5.64M	7.42M	6.29M	7.58M	6.68M	3.58M	4.00M	4.68M	7.56M	12.42M	8.77M	10.04M	5.65M	10.02M	8.45M
Accumulated Expenses							0.03M											7.64M	9.80M	11.98M
Other Accumulated Expenses	0.34M	0.44M	0.39M	1.09M	0.76M	0.26M	0.55M	0.64M	1.25M	0.25M	0.47M	0.31M	0.38M	0.48M	0.38M	0.24M	0.52M	0.50M	0.83M	1.20M
Current Taxes
Current Deferred Revenue																			0.42M	1.03M
Total Current Liabilities	5.85M	6.78M	4.61M	4.26M	6.52M	6.14M	7.96M	6.81M	8.11M	7.23M	4.13M	4.57M	5.26M	8.13M	12.96M	9.28M	10.52M	13.98M	20.94M	22.18M
Non-Current Liabilities
Preferred Stock Liabilities
Operating Leases	0.51M	0.47M	0.43M	0.38M	2.09M	2.00M	1.86M	1.73M	1.58M	1.46M	1.31M	1.16M	1.00M	0.87M	0.76M	0.64M	0.52M	0.54M	0.37M	0.19M
Other Non-Current Liabilities	52.93M	52.94M	52.94M	52.94M	52.94M	34.35M	48.46M	48.46M	48.46M	48.46M	53.08M	53.08M	53.08M	53.08M	53.08M	53.08M	55.65M	55.73M	55.72M	55.71M
Total Non-Current Liabilities	-46.57M	-45.69M	-47.90M	-48.30M	-44.33M	-26.22M	8.69M	8.15M	10.15M	10.00M	3.00M	4.18M	5.62M	9.28M	14.93M	12.09M	11.60M	16.06M	101.96M	107.70M
Total Liabilities	6.36M	7.25M	5.04M	4.64M	8.61M	8.14M	57.15M	56.61M	58.61M	58.46M	56.08M	57.25M	58.69M	62.35M	68.01M	65.16M	67.25M	71.79M	157.69M	163.41M
Shareholder's Equity
Total Debt							47.32M	48.07M	48.92M	49.77M	50.64M	51.53M	52.43M	53.35M	54.29M	55.24M	56.21M	57.19M	58.19M	59.21M
Common Equity	127.42M	112.60M	100.76M	86.66M	77.16M	66.35M	53.94M	40.41M	28.50M	16.77M	39.92M	31.98M	24.01M	13.15M	-6.12M	-17.75M	20.50M	41.77M	36.05M	18.22M
Liabilities and Shareholders Equity	133.78M	119.85M	105.80M	91.30M	85.77M	74.48M	111.08M	97.02M	87.12M	75.23M	96.00M	89.23M	82.71M	75.50M	61.89M	47.42M	87.75M	113.56M	193.73M	181.63M
Retained Earnings	-189.44M	-207.95M	-220.33M	-237.00M	-251.53M	-266.34M	-281.30M	-297.33M	-312.42M	-326.03M	-336.40M	-345.74M	-355.20M	-367.55M	-388.31M	-401.30M	-413.20M	-430.60M	-456.70M	-485.30M

Milestone Pharmaceuticals Balance Sheet API

Pull Milestone Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MIST&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "MIST", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=MIST&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Milestone Pharmaceuticals MIST Balance Sheet (2018-2026)

Milestone Pharmaceuticals Quarterly Balance Sheet

Milestone Pharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password